genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Biomarkers
Biomarkers Identified to Help Predict Risk of Pancreatic Cyst Progression to…
Antifungals
Cases of Candida auris Fungal Infection Dramatically Increase in U.S.
Microbiology
Helping Beneficial Bacteria Survive in the Human Gut
Aging
Researchers Reveal How an Enzyme Affects Muscle Health
Eye Disorders
Prime Editing Reverses Vision Loss in Mice
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Cancer
Lightspeed’s Jonathan MacQuitty and the Laws of Biotech Relativity
Biologics
Biologics Manufacturing without the Cells
Bioprocessing
Bio-Inspired Coatings Could Make Cell Activation More Efficient in Therapy Production
Bioprocessing
Vortex-Focusing Microfluidics Yields Precisely Sized Liposomes at Scale
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
T Cells
CAR T-Cells
CAR T-Cells
CAR T-Cells
Dendritic Cells
7 days popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
CAR T-Cells
Amgen, MD Anderson Launch Two Cancer Collaborations
CAR T-Cells
VEGF-A Found Critical in Helping T Cells to Kill Tumors
CAR T-Cells
CAR-Engineered Blood Stem Cells Offer New Hope for Long-Term HIV Gene...
CAR T-Cells
Regeneron to Invest $100M in bluebird bio as Companies Partner in...
CAR T-Cells
3D Bioscaffold Mimics Antigen-Presenting Cells for Improved T-Cell Expansion
CAR T-Cells
Identification of Sprouty 1 and Sprouty 2 Provide Basis for New...
CAR T-Cells
Coronado Inks Deal with NeuPharma, Creates New Company with City of...
CAR T-Cells
Cancer Immunotherapy Channeled via Remote Control
CAR T-Cells
Formula, Rockland Launch Cancer Immunotherapy Collaboration
CAR T-Cells
Novel Biomaterials Boost T-Cell Production
1
2
Page 1 of 2
Scroll Up
![Regeneron Pharmaceuticals demonstrated its VelocImmune technology in a study published in 2015 in Proceedings of the National Academy of Sciences showing the rapid generation of fully human neutralizing antibodies against Middle East Respiratory Syndrome coronavirus (MERS-CoV) and development of a humanized mouse model for MERS-CoV infection (pictured). Regeneron will use VelocImmune and other VelociSuite platform technologies in a collaboration with bluebird bio to develop new immune cell therapies for cancer. [Source: PNAS]](https://www.genengnews.com/wp-content/uploads/2018/08/F7large2321726613-324x160.jpg "Regeneron to Invest $100M in bluebird bio as Companies Partner in Cancer Therapies")
